Published in J Natl Cancer Inst on June 01, 1971
A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera. J Exp Med (1972) 1.92
A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J Exp Med (1973) 1.68
Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 1.55
Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus. Proc Natl Acad Sci U S A (1974) 1.26
Helper-dependent properties of Friend spleen focus-forming virus: effect of the Fv-1 gene on the late stages in virus synthesis. J Virol (1973) 1.03
Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 0.97
Immunodepression by Rowson-Parr virus in mice. II. Effect of Rowson-Parr virus infection on the antibody response to sheep red cells in vivo and in vitro. Infect Immun (1973) 0.91
Immunodepression by Rowson-Parr virus in mice. I. Growth curves of Rowson-Parr virus and immunological relationships with Friend virus. Infect Immun (1973) 0.88
Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection. Virology (2013) 0.83
Helper activity of human leukemic tissue extracts for leukemia virus expression in mice. Proc Natl Acad Sci U S A (1971) 0.82
Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component. J Exp Med (1977) 0.77
Immunodepression by Rowson-Parr virus in mice; lymphocyte markers and capping response of spleen and lymph node cells after infection. Infect Immun (1976) 0.75
Differential susceptibility of spleen focus-forming virus and murine leukemia viruses to ansamycin antibiotics. Antimicrob Agents Chemother (1977) 0.75
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol (1996) 10.39
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci U S A (1983) 3.76
Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex. J Natl Cancer Inst (1971) 2.94
Editorial: Spleen focus-forming virus in Friend and Rauscher leukemia virus preparations. J Natl Cancer Inst (1975) 2.83
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob Agents Chemother (1991) 2.66
Cellular differentiation of the immune system of mice. I. Separate splenic antigen-sensitive units for different types of anti-sheep antibody-forming cells. J Exp Med (1968) 2.51
Expression of a retrovirus encoding human HPRT in mice. Science (1984) 2.48
B-tropic Friend virus: a host-range pseudotype of spleen focus-forming virus (SFFV). Virology (1973) 2.34
A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera. J Exp Med (1972) 1.92
Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Stroke (1997) 1.89
Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein. J Virol (1974) 1.87
Host-induced changes in infectivity of Friend spleen focus-forming virus. J Natl Cancer Inst (1970) 1.59
Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55
Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States) Cancer Causes Control (1997) 1.51
Cellular differentiation of the immune system of mice. V. Class differentiation in marrow precursors of plaque-forming cells. J Exp Med (1969) 1.50
Spleen focus formation by polycythemic strains of Friend leukemia virus. Proc Soc Exp Biol Med (1968) 1.49
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol (2000) 1.39
Measuring response to a cancer information telephone facility: Can-Dial. Am J Public Health (1976) 1.39
Cellular antigen of Friend virus-induced leukemias. Cancer Res (1968) 1.33
Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol (1997) 1.32
Cellular differentiation of the immune system of mice. IV. Lack of class differentiation in thymic antigen-reactive cells. J Exp Med (1969) 1.31
Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus. J Virol (1977) 1.28
Interleukin 3-dependent hematopoietic progenitor cell lines. Fed Proc (1983) 1.27
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis (1991) 1.26
Cellular differentiation of the immune system of mice. II. Frequency of unipotent splenic antigen-sensitive units after immunization with sheep erythrocytes. J Exp Med (1969) 1.26
Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method. Int J Cancer (1967) 1.26
Can-Dial. An experiment in health education and cancer control. Public Health Rep (1976) 1.20
The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem (1979) 1.19
Mechanisms of genetic resistance to friend virus leukemia in mice. J Exp Med (1974) 1.19
Mechanism of testosterone action in erythropoiesis. Nature (1965) 1.16
Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport (2000) 1.15
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology (1997) 1.14
Can-Dial: a dial access cancer education service. Int J Health Educ (1977) 1.14
Utilization of a cancer telephone information facility: a comparison of callers and non-caller controls. Am J Public Health (1978) 1.13
Information in natural languages. A new approach. JAMA (1969) 1.13
Prospective evaluation of the Ottawa Ankle Rules in a university sports medicine center. With a modification to increase specificity for identifying malleolar fractures. Am J Sports Med (1998) 1.12
In vitro production of erythropoietin by mouse fetal liver. Blood (1975) 1.11
Mutant Sl alleles of mice affect susceptibility to Friend spleen focus-forming virus. Science (1968) 1.10
Murine viral-induced polycyhemia. Ann N Y Acad Sci (1968) 1.09
Virus-induced polycythemia in mice: erythropoiesis without erythropoietin. Proc Soc Exp Biol Med (1968) 1.08
Release of spleen focus-forming virus (SFFV) from differentiation inducible promyelocytic leukemia cell lines transformed in vitro by Friend leukemia virus. Virology (1980) 1.08
Genetic control by the W locus of susceptibility to (Friend) spleen focus-forming virus. Nature (1968) 1.08
Immunocompetent cell functions in mice infected with Friend leukemia virus. J Natl Cancer Inst (1970) 1.07
Cancer information by telephone: a two-year evaluation. Health Educ Monogr (1977) 1.07
Enhancement of spleen focus formation and virus replication in Friend virus-infected mice. Cancer Res (1969) 1.07
Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia. J Am Geriatr Soc (2001) 1.06
Identification of erythropoietin producing cells in fetal mouse liver cultures. Exp Hematol (1977) 1.06
Vertical transmission of murine leukemia virus. Cancer Res (1969) 1.06
A statistical method for the estimation of binding parameters in a complex system. Anal Biochem (1976) 1.03
Helper-dependent properties of Friend spleen focus-forming virus: effect of the Fv-1 gene on the late stages in virus synthesis. J Virol (1973) 1.03
Androgen actions on erythropoiesis. Ann N Y Acad Sci (1968) 1.02
Mycoplasmas (PPLO) and human leukemia and lymphoma. Cancer (1965) 1.01
Virus-induced erythropoiesis in hypertransfused-polycythemic mice. Science (1967) 1.00
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J Neuroimmunol (1999) 1.00
Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 0.97
Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci (2001) 0.96
Prognostic factors in patients with advanced stage prostate cancer. Cancer Res (1985) 0.96
Mechanisms of prednisolone action in erythropoiesis. Endocrinology (1967) 0.96
Relative reliability of five serially measured markers for prognosis of progression in prostate cancer. J Natl Cancer Inst (1986) 0.96
Temperature-dependent versus constant-rate blood perfusion modelling in ferromagnetic thermoseed hyperthermia: results with a model of the human prostate. Int J Hyperthermia (1994) 0.95
In vitro malignant transformation of cells by Friend virus. Nature (1966) 0.94
Origin of spleen colonies generated by Friend virus-infected cells in mice. Cancer Res (1978) 0.93
Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol (1993) 0.93
Bone marrow colony-stimulating factor following ureteral igation in germfree mice. Proc Soc Exp Biol Med (1970) 0.93
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. Invest Ophthalmol Vis Sci (1998) 0.92
Hormones in renal cancer. J Urol (1977) 0.91
Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change. J Exp Med (1979) 0.90
A genetic analysis of melanoma--polygenic inheritance as a threshold trait. Am J Epidemiol (1981) 0.90
Spleen foci and polycythemia in C57B1 mice infected with host-adapted Friend leukemia virus. Int J Cancer (1970) 0.90
Defective Friend spleen focus-forming virus: pseudotype neutralization by helper-specific antisera. Nat New Biol (1971) 0.90
Hyperthermia and irradiation for locally recurrent previously irradiated breast cancer. Strahlenther Onkol (1991) 0.89
Immunogenetic analysis of the mechanism of induction of Friend virus leukemia. Transplant Proc (1975) 0.88
Erythropoietic response of animals infected with various strains of Friend virus. Natl Cancer Inst Monogr (1966) 0.88
The Ordac method of making age adjustments in data. J Chronic Dis (1964) 0.87
Mechanism of estrogen action in erythropoiesis. Endocrinology (1966) 0.87
The Fv-2r resistance gene in mice: its effect on spleen colony formation by Friend virus-transformed cells. J Natl Cancer Inst (1976) 0.87
A comparison of various types of patient instruction in the proper administration of metered inhalers. Drug Intell Clin Pharm (1982) 0.87
Extra-renal production of erythropoietin in man. Acta Haematol (1968) 0.87
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. Int J Radiat Oncol Biol Phys (1990) 0.86
Retroperitoneal paragangliomas: natural history and review of the literature. Wis Med J (1995) 0.86
Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol (1984) 0.86
Passive and active immunity to Friend virus disease. Nature (1966) 0.86
Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in an Escherichia coli model of gram-negative pneumonitis in rats. Infect Immun (2000) 0.86
Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia. Cancer Res (1983) 0.85
In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria. J Pharmacol Exp Ther (1983) 0.84
Cigarette smoking and periodontal disease. J Am Dent Assoc (1968) 0.84